American Medical Association House of Delegates 2016
Chicago, Ill June 11-June 15, 2016
APCR Secretary Peter Rheinstein, MD, JD attended the AMA Annual meeting of the House of Delegates as the delegate for APCR. The meeting was in Chicago starting June 11 and concluding June 15. The majority of the issues discussed did not directly affect physicians in clinical research.
One topic of particular interest to APCR was the AMA Board of Trustees (BOT) Report 23 - Removing Financial Barriers to Participation in Clinical Trials for Medicare Beneficiaries and H.R. 6, 21st Century Cures Act. This Report was extracted for discussion as the last item of business in Reference Committee B and extracted again by the Speakers for discussion shortly before the close of the meeting on Wednesday morning. BOT Report 23 was an Informational Report setting forth the new AMA Policy crafted by the AMA Board of Trustees in response to Resolutions introduced by APCR and the Georgia Delegation at last November’s meeting of the House of Delegates. Informational Reports normally are accepted for filing without discussion by the House of Delegates. Dr. Rheinstein stood by the microphone, but in the end, the report received no discussion on the floor of the House of Delegates and our requested language is now official AMA policy. The annotated Reference Committee reports (showing changes made on the floor of the House of Delegates) have been posted to the AMA website.
American Medical Association House of Delegates 2015
As a member of the American Medical Association’s (AMA) House of Delegates, APCR appoints one delegate to represent the Academy before the House. APCR may introduce resolutions to be debated and voted on by the House. These resolutions form the foundation of the AMA’s policy and dictate its actions.